Platelet-rich plasma ‘a promising treatment for heart attacks’January 18th, 2011 - 6:31 pm ICT by ANI
Washington, Jan 18 (ANI): Platelet-rich plasma is a promising biologic treatment for myocardial infarction (heart attack), according to researchers at the Stanford University School of Medicine.
Platelet-rich plasma (PRP) has already been identified as a novel biologic treatment for wound healing and sports-related injuries. But it was only recently that scientists began studying PRP’s potential in repairing damaged cardiovascular tissue.
Studies indicate PRP stimulates cell repair via growth factor release and by attracting reparative cells.
Lead author Allan Mishra and his colleagues studied the effects of RevaTen PRP (a proprietary formulation of concentrated platelets and white blood cells) on cardiac function after inducing cardiac ischemia (damage to myocardial tissue caused by blood restriction) in mice.
In this study of 28 mice, they induced ischemia by either permanently occluding the left anterior descending artery (Group A) or temporarily ligating it for 45 minutes (Group B).
The hearts were then injected with RevaTen PRP or saline control.
In both groups, mice that received PRP after ischemia had significantly better cardiac function as measured by left ventricular ejection fraction on MRI than those that had been injected with saline only.
In group A, the RevaTen-treated animals had 38 percent better ejection fraction compared to saline controls.
In group B, the RevaTen-treated animals had 28 percent improvement in ejection fraction compared to controls.
“Although this is an observational study using an animal model, PRP might someday be employed at the point of care to treat patients who have had a heart attack. This could preserve cardiac function and limit the progression to congestive heart failure,” said Mishra.
“Since myocardial infarction remains the leading cause of death in industrial nations, RevaTen PRP may become a powerful biologic tool in fighting heart disease and provide cost savings,” he added.
The findings were published online in Cardiovascular Revascularization Medicine. (ANI)
- New stem cells could help heal damaged hearts - Dec 23, 2011
- Short-term, high-fat diet 'may cut heart attack damage' - Apr 14, 2011
- First trial of bone-marrow stem cells for heart attack proves safe - Sep 15, 2010
- Stem cell patch may improve function after heart attack - Nov 16, 2010
- 'Grafting helps normalise heartbeats' - Aug 06, 2012
- Post-menopause, women more vulnerable to heart attacks - Jun 12, 2012
- Researchers patch damaged heart with engineered tissue - May 08, 2011
- Platelet Rich Plasma Therapy shows promise for knee osteoarthritis - Nov 21, 2010
- Stem cells transplanted into mice embryo protect heart - May 15, 2009
- Specific blood-derived cells promote survival in heart attack mouse model - Jun 17, 2010
- Reversing the bald fact - shots to restore hair growth - May 10, 2011
- Patients' own stem cells could be used as treatment for their heart disease - Nov 18, 2010
- Chemical in soap, toothpaste impairs muscle strength - Aug 14, 2012
- Scientists find 13 new genes linked to heart diseases - Mar 07, 2011
- Molecular 'playbook' to stop heart failure risk factor found - Sep 24, 2010
Tags: allan mishra, animal model, cardiac function, congestive heart failure, heart attacks, heart failure, left anterior descending artery, left ventricular ejection fraction, myocardial infarction, myocardial tissue, observational study, platelet rich plasma, promising treatment, proprietary formulation, prp, stanford university school, stanford university school of medicine, ventricular ejection fraction, white blood cells, wound healing